Get started

BridgeBio Pharma, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

BBIO chart

Key stats

Market capitalization
5.017BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.91USD
Net income
−481.183MUSD
Revenue
77.648MUSD
Shares float
124.951M
Beta
1.55

About BridgeBio Pharma, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Neil Kumar
Website
bridgebio.com
Headquarters
Palo Alto
Employees (FY)
396
Founded
2015
ISIN
US10806X1028
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Ideas

#BBIO bearish sentimentParty at the BBIO market!!!! Meanwhile, SOMEONE is selling a uncovered 30 call for more than $8.2 M$ with a maturity of 18-Aug-23, indicating a bearish sentiments. The rationale is that the 30 call seller anticipates prices to fall below $30 by that date.
by ClashChartsTeam
bbio daily buy/hold setup 200% gains strong chart🔸Hello guys, let's review the daily price chart for BBIO today. Noteworthy compression in progress, and also a decent sequence of higher lows, therefore expecting more gains in BBIO. Short-term pullback into May/June, however should find support near 10 usd later. Currently trading at 15.85 usd. Ope
Long
by ProjectSyndicate
17
BridgeBio Making bridges to bigger broker accounts. BBIO Yes, another pharma stock in the green. Let's go, baby! We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing
Long
by Rykin_Capital
BBIO Long after the sell offAfter looking at the huge selloff and seeing where we have been with this stock. It looks as if it is ready to grow long here to the first resistance of ~$20. then it will make that a new support line to head north to ~$32 where the analysts have placed it as valued.
Long
by GlennTrading
5
BBIO trade ideaAscending triangle with resistance at 71.84 blue line and higher lows with red trendline as support. Target price: $92.51 Trade idea 3 buying opportunity 1. buy when price bounce at red line showing support, and stop loss below red line at $57.84 2. buy when price cross blue line at $71.84, and s
Long
by locusyuenab

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers